Daniel J. O'Connor's Net Worth
Estimate Recalculated Sep 9, 2024 12:30AM EST
Who is Daniel J. O'Connor
Daniel J. O'Connor does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ZyVersa Therapeutics, Inc., Ambrx Biopharma, Inc., Advaxis, Inc., SEELOS THERAPEUTICS, INC., ONCOSEC MEDICAL Inc, Ambrx Biopharma Inc., and IMCLONE SYSTEMS INC.
SEC CIK
Daniel J. O'Connor's CIK is 0001376847
Past Insider Trading and Trends
2013 was Daniel J. O'Connor's most active year for acquiring shares with 20 total transactions. Daniel J. O'Connor's most active month to acquire stocks was the month of December. 2016 was Daniel J. O'Connor's most active year for disposing of shares, totalling 15 transactions. Daniel J. O'Connor's most active month to dispose stocks was the month of December. 2018 saw Daniel J. O'Connor paying a total of $401,600.50 for 3,526,667 shares, this is the most they've acquired in one year. In 2023 Daniel J. O'Connor cashed out on 50,012 shares for a total of $491,117.84, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
